TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29626933

Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN to develop an individualized eating plan (Group A)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN and a structured meal plan (Group B)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN, a structured meal plan, and weekly phone support (Group C)
Number of subjects: 108
Study: 27613582

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 5135

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus (DM)
Number of subjects: 5135

Group type: COMPARATOR
Intervention: Normal glucose
Number of subjects: 5135
Study: 25974092

Group type: EXPERIMENTAL
Intervention: Integrated care program (Progetto Diabete Calabria)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Ordinary outpatient medical management
Number of subjects: 312
Study: 23823799

Group type: EXPERIMENTAL
Intervention: Agomelatine (25-50 mg/d)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Escitalopram (10-20 mg/d)
Number of subjects: 324
Study: 21411474

Group type: EXPERIMENTAL
Intervention: Incentive structure (various combinations of individual and pair compensation)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Web vs. mail data collection mode
Number of subjects: 224

Group type: COMPARATOR
Intervention: Short vs. long questionnaire length
Number of subjects: 224

Group type: COMPARATOR
Intervention: Incentive structures (4 different combinations)
Number of subjects: 224
Study: 18312763

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg and Fenofibrate 160 mg (Combination therapy)
Number of subjects: 498
Study: 16768549

Group type: EXPERIMENTAL
Intervention: Polychromatic light (480-3400 nm) at a therapeutic dose of 12 J/cm²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro irradiation of blood (2.4 J/cm²)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irradiated blood mixed 1:10 with nonirradiated autologous blood
Number of subjects: 0
Study: 14605061

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lobectomy (control group)
Number of subjects: 10
Study: 11149164

Group type: EXPERIMENTAL
Intervention: Tight control of diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photocoagulation laser therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prompt diagnosis and treatment for endophthalmitis and mucormycosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergent ophthalmologic evaluation and treatment for herpes zoster infection
Number of subjects: 0
Study: 8731519

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg DMT fumarate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 13
Study: 8329110

Group type: EXPERIMENTAL
Intervention: Paternal lymphocyte immunization (400 million paternal lymphocytes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maternal (autologous) lymphocyte immunization (400 million maternal lymphocytes)
Number of subjects: 0
Study: 2945967

Group type: EXPERIMENTAL
Intervention: Computer-based approach
Number of subjects: 8

Group type: COMPARATOR
Intervention: Traditional intervention techniques
Number of subjects: 8
Study: 30844986

Group type: EXPERIMENTAL
Intervention: Vibration in the direction of the resultant muscle forces' vector (VDF) at frequencies of 10, 20, 30, or 40 Hz
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Whole‐body vibration (WBV) at frequencies of 10, 20, 30, or 40 Hz
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maximal voluntary contractions (MVCs) without vibration
Number of subjects: 20
Study: 30074002

Group type: EXPERIMENTAL
Intervention: Gutta‐percha with AH Plus
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Resilon with Epiphany SE
Number of subjects: 56
Study: 27259529

Group type: EXPERIMENTAL
Intervention: Sutureless securement devices
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Integrated securement dressings
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 328

Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 328
Study: 24990296

Group type: EXPERIMENTAL
Intervention: LED curing modes (conventional, pulse-delay, ramped)
Number of subjects: 100

Group type: COMPARATOR
Intervention: QTH curing
Number of subjects: 100
Study: 22858744

Group type: EXPERIMENTAL
Intervention: Air-Stirrup ankle brace
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fiberglass posterior splint
Number of subjects: 45
Study: 19577308

Group type: EXPERIMENTAL
Intervention: SRI treatment (clomipramine, fluvoxamine, or fluoxetine)
Number of subjects: 165
Study: 18664593

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (3 sessions/wk; running at 60 and 90% of peak oxygen consumption in 4-min intervals for a total of 32 min; gross energy expenditure: 446+/‐29 kcal)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 7

Group type: COMPARATOR
Intervention: Nonexercising control group (n=8)
Number of subjects: 7
Study: 16200596

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12954464

Group type: EXPERIMENTAL
Intervention: 2 days interval
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2 weeks interval
Number of subjects: 70
Study: 11789183

Group type: EXPERIMENTAL
Intervention: Yiqi Yangyin Huoxue recipe (YQYYHX)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 9010690

Group type: EXPERIMENTAL
Intervention: ketoprofen 3 x 25 mg per day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ketoprofen 3 x 50 mg per day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ibuprofen 3 x 200 mg per day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ibuprofen 3 x 400 mg per day
Number of subjects: 12
Study: 1504643

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (50 micrograms/70 kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study: 6421508

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 2 g/l
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 20 g/l
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 40 g/l
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study: 31443961

Group type: EXPERIMENTAL
Intervention: Adjuvant docetaxel 75 mg/m2 every 3 weeks for 6 cycles (arm A)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Surveillance (arm B)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Adjuvant docetaxel (arm A)
Number of subjects: 376
Study: 29480202

Group type: EXPERIMENTAL
Intervention: Non-medical sport university site providing free access to group exercise in a sports environment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Memory clinics linked to hospitals
Number of subjects: 0
Study: 27191518

Group type: EXPERIMENTAL
Intervention: Standard educational session
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Standard information and brochure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Standard information and informative video
Number of subjects: 40
Study: 25421903

Group type: EXPERIMENTAL
Intervention: Low-cost bubble CPAP device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal oxygen therapy
Number of subjects: 0
Study: 22298340

Group type: EXPERIMENTAL
Intervention: Enhanced Voluntary Counseling and Testing (EVCT)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Standard Voluntary Counseling and Testing (SVCT)
Number of subjects: 295
Study: 20663185

Group type: EXPERIMENTAL
Intervention: Weight Watchers
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Slimming World
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Rosemary Conley
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Size Down (group-based dietetics-led programme)
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: General practice one-to-one counselling
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Pharmacy-led one-to-one counselling
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Choice of any of the 6 programmes
Number of subjects: 740

Group type: COMPARATOR
Intervention: Minimal intervention control (12 vouchers for local leisure centre)
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 740
Study: 18928633

Group type: COMPARATOR
Intervention: Glucocorticoid treatment (n = 35)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Anti-HP treatment (n = 30)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Combined treatment (glucocorticoid + HP eradication, n = 35)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (100 healthy individuals)
Number of subjects: 100
Study: 15812603

Group type: EXPERIMENTAL
Intervention: Negatively valenced slides
Number of subjects: 15

Group type: COMPARATOR
Intervention: Neutral slides
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Positively valenced slides
Number of subjects: 15
Study: 12421156

Group type: EXPERIMENTAL
Intervention: Optimal tint glasses
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control tint glasses
Number of subjects: 17
Study: 10512960

Group type: EXPERIMENTAL
Intervention: Implant-supported overdenture (IOD)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional denture (CD)
Number of subjects: 89
Study: 7796075

Group type: EXPERIMENTAL
Intervention: Dietary therapy
Number of subjects: 15
Study: 1838281

Group type: EXPERIMENTAL
Intervention: Experimental resin sealant (ICI 209085)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Light Cured Tinted Delton (control)
Number of subjects: 60
Study: 6512581

Group type: EXPERIMENTAL
Intervention: Intrathoracic BCG
Number of subjects: 473

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 473
Study: 31179883

Group type: EXPERIMENTAL
Intervention: TURis
Number of subjects: 168

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 168
Study: 28495389

Group type: EXPERIMENTAL
Intervention: Antibiotics scenario
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Equipoise scenario
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Vaccine-hesitancy scenario
Number of subjects: 132

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 132
Study: 26102259

Group type: EXPERIMENTAL
Intervention: Packs
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vest
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study: 23948845

Group type: EXPERIMENTAL
Intervention: Local Corrective Exercise Program (LCEP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comprehensive Corrective Exercise Program (CCEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 22425732

Group type: EXPERIMENTAL
Intervention: Step stool
Number of subjects: 50
Study: 19010622

Group type: EXPERIMENTAL
Intervention: Anti-acetonemic diet
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (no diet intervention)
Number of subjects: 1200
Study: 17551901

Group type: EXPERIMENTAL
Intervention: High cut-off hemodialysis (HCO-HD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard high-flux hemodialysis (HF-HD)
Number of subjects: 10
Study: 15185877

Group type: EXPERIMENTAL
Intervention: Active drug (ranitidine, 150 mg b.d.)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 11346473

Group type: EXPERIMENTAL
Intervention: Computer‐mediated interactive voice response (IVR) system integrated with voicemail; 18-month study duration.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned);
Number of subjects: 100
Study: 9701194

Group type: EXPERIMENTAL
Intervention: Short-chain fructans (10-30 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Long-chain fructans (10-30 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fructose (50 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sorbitol with equimolar glucose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Short-chain fructans
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Long-chain fructans
Number of subjects: 10
Study: 7977881

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate reduced-dose group (average 11.5 mg every 2 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fluphenazine decanoate control group (23 mg every 2 weeks)
Number of subjects: 43
Study: 2521321

Group type: EXPERIMENTAL
Intervention: Microgynon 30
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Marvelon
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Triquilar
Number of subjects: 100
Study: 1071665

Group type: EXPERIMENTAL
Intervention: Phentolamine administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normotensive control subjects (no intervention)
Number of subjects: 0
Study: 30832288

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-24)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-42)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-56)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study: 27552500

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1% 3 times daily for 1 week
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% 3 times daily for 1 week
Number of subjects: 132

Group type: COMPARATOR
Intervention: No anti-inflammatory treatment
Number of subjects: 132
Study: 26312576

Group type: EXPERIMENTAL
Intervention: GH 1.0 U
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GH 2.5 U
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 80
Study: 24035633

Group type: EXPERIMENTAL
Intervention: Lurasidone 160 mg/day
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (200-800 mg)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267

Group type: COMPARATOR
Intervention: All treatments (Lurasidone 80 mg, Lurasidone 160 mg, Quetiapine XR, Placebo)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Lurasidone (40-160 mg)
Number of subjects: 267
Study: 22123802

Group type: EXPERIMENTAL
Intervention: Antibiotics (omeprazole, amoxicillin trihydrate, and clarithromycin) for 10 days
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control (omeprazole plus placebo) for 10 days
Number of subjects: 404
Study: 19018785

Group type: EXPERIMENTAL
Intervention: Ergocalciferol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Number of subjects: 56
Study: 18089259

Group type: EXPERIMENTAL
Intervention: Watching music videos with thin models
Number of subjects: 87

Group type: COMPARATOR
Intervention: Listening to music from the videos
Number of subjects: 87

Group type: COMPARATOR
Intervention: Learning a list of words
Number of subjects: 87
Study: 15257176

Group type: EXPERIMENTAL
Intervention: rilmenidine 1 mg twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 11166979

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ketorolac 20 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 9880180

Group type: EXPERIMENTAL
Intervention: HA/TCP coated tibial component
Number of subjects: 36

Group type: COMPARATOR
Intervention: Uncoated tibial component
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 7997386

Group type: EXPERIMENTAL
Intervention: Intravenous fructose‐1,6‐diphosphate 125 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline 1.3 ml/kg
Number of subjects: 0
Study: 3348162

Group type: EXPERIMENTAL
Intervention: Sodium loading at 128 mmol/d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium loading at 256 mmol/d
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control period (low-Na diet)
Number of subjects: 10
Study: 30108107

Group type: EXPERIMENTAL
Intervention: ENMD-2076
Number of subjects: 40
Study: 27621583

Group type: EXPERIMENTAL
Intervention: CO2 insufflation (n = 24)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Air insufflation (n = 22)
Number of subjects: 46
Study: 24736773

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) - 12 weeks of squat MST at 85-90% of 1RM
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG) - encouraged to follow ACSM exercise guidelines
Number of subjects: 30
Study: 22268911

Group type: EXPERIMENTAL
Intervention: Uppercase, rhyme, or category‐membership judgments about words with immediate recall after every 3 or 8 processing judgments.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surprise immediate recall of 8‐item lists.
Number of subjects: 0
Study: 20087376

Group type: EXPERIMENTAL
Intervention: Multivitamins and 7 mg Zinc daily for 10 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Multivitamins only
Number of subjects: 30
Study: 18174214

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex: 2 x 2 mg per day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 9
Study: 15486010

Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 microg kg(‐1) at induction
Number of subjects: 62

Group type: COMPARATOR
Intervention: No fentanyl
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (fentanyl and no fentanyl)
Number of subjects: 62
Study: 12452874

Group type: EXPERIMENTAL
Intervention: 50 U BTX‐A (Botox, Allergan, Inc.)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: BTX‐A
Number of subjects: 320
Study: 10326325

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate tablets containing 60 mg of elemental iron
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate tablets containing 120 mg of elemental iron
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate tablets containing 180 mg of elemental iron
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ferrous fumarate syrup
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Gelatin capsules containing pure ferrous salt
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ferrous fumarate tablets
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Powdered ferrous sulphate tablets
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Iron tablets distributed by the NNAPP
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Excipients added to pure ferrous sulphate salts
Number of subjects: 115
Study: 8622045

Group type: EXPERIMENTAL
Intervention: Third-generation chemotherapy regimens (F-MACHOP or MACOP-B)
Number of subjects: 90
Study: 1933116

Group type: EXPERIMENTAL
Intervention: Textured surface silicone implants
Number of subjects: 53

Group type: COMPARATOR
Intervention: Smooth surface silicone implants
Number of subjects: 53
Study: 7310012

Group type: EXPERIMENTAL
Intervention: Lodoxamide tromethamine (0.1 mg in saline)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 15
Study: 30192638

Group type: EXPERIMENTAL
Intervention: Mepolizumab (750 mg intravenously)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0
Study: 28064380

Group type: EXPERIMENTAL
Intervention: PFN-a surgery
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Non-drainage
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: BMI < 25 kg/m2
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Admission specific gravity of urine > 1.020
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Admission albumin < 30 g/L
Number of subjects: 89
Study: 25545810

Group type: EXPERIMENTAL
Intervention: pf‐PVA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: oc‐PVA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: s‐PVA
Number of subjects: 90
Study: 25711249

Group type: EXPERIMENTAL
Intervention: Open Chernousov modified Nissen fundoplication (CMNF)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Laparoscopic total fundoplication
Number of subjects: 243
Study: 21135547

Group type: EXPERIMENTAL
Intervention: short-term low dietary protein intake (DPI) supplemented with keto acids
Number of subjects: 40

Group type: COMPARATOR
Intervention: normal dietary protein intake (NP)
Number of subjects: 40
Study: 19335534

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Sulfonylurea (SU) or combination of SU/metformin (Met)/thiazolidinediones (TZD)
Number of subjects: 2368

Group type: COMPARATOR
Intervention: Metformin (Met)/Thiazolidinediones (TZD)
Number of subjects: 2368
Study: 17991260

Group type: EXPERIMENTAL
Intervention: Rectal diclofenac 1 mg.kg(‐1)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Paracetamol 40 mg.kg(‐1)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combination of rectal diclofenac and paracetamol
Number of subjects: 108
Study: 15790458

Group type: EXPERIMENTAL
Intervention: Cisplatin plus paclitaxel (PT)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (TC)
Number of subjects: 302
Study: 12473557

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 86
Study: 9481597

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 5 mg sibutramine
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 10 mg sibutramine
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 15 mg sibutramine
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 10 mg and 15 mg sibutramine
Number of subjects: 235
Study: 7638922

Group type: EXPERIMENTAL
Intervention: Sonographic examination of the knee joint
Number of subjects: 193

Group type: COMPARATOR
Intervention: Clinical tests of stability (Lachmann)
Number of subjects: 193